Literature DB >> 12882466

Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome.

N Meslier1, F Gagnadoux, P Giraud, C Person, H Ouksel, T Urban, J L Racineux.   

Abstract

The aim of this cross-sectional study was to evaluate the frequency of type-2 diabetes and impaired glucose tolerance (IGT) in a large clinic-based male population presenting various degrees of obstructive sleep apnoea syndrome (OSAS) and to analyse the relationship between OSAS and glucose-insulin metabolism. Male patients (n=595) with suspected OSAS underwent both nocturnal polysomnography and a 2-h oral glucose-tolerance test with measurements of fasting and postload blood glucose and plasma insulin. Insulin sensitivity was evaluated by the ratio of fasting glucose to fasting insulin. OSAS was diagnosed in 494 patients, while 101 patients were nonapnoeic snorers. Type-2 diabetes was present in 30.1% of OSAS patients and 13.9% of nonapnoeic snorers. IGT was diagnosed in 20.0% of OSAS patients and 13.9% of nonapnoeic snorers. Fasting and postload blood glucose increased with severity of sleep apnoea. Insulin sensitivity decreased with increasing severity of sleep apnoea. In addition to body mass index and age, the apnoea/hypopnoea index independently influenced postload blood glucose and insulin sensitivity. The authors conclude that in a clinic-based sample of patients, obstructive sleep apnoea syndrome is associated with a high frequency of type-2 diabetes and impaired glucose tolerance. The relationship between sleep-disordered breathing and impaired glucose-insulin metabolism is independent of obesity and age.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12882466     DOI: 10.1183/09031936.03.00089902

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  80 in total

1.  Impaired fasting plasma glucose and stroke risk.

Authors:  Teck Kim Khoo
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

2.  The assessment of sleep apnoea as a risk factor in glaucoma.

Authors:  Tejaswini Prashant Khandgave; Neelam Puthran; Avinash B Ingole; Anjali D Nicholson
Journal:  J Clin Diagn Res       Date:  2013-07-01

3.  Screening for type 2 diabetes in patients with obstructive sleep apnoea.

Authors:  C Snelson; R Chandrappa; H Moudgil
Journal:  Thorax       Date:  2007-07       Impact factor: 9.139

4.  Symptoms of obstructive sleep apnea in patients with nonalcoholic fatty liver disease.

Authors:  Harminder Singh; Richard Pollock; Julia Uhanova; Meir Kryger; Kim Hawkins; Gerald Y Minuk
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

5.  Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

Authors:  R Nisha Aurora; Naresh M Punjabi
Journal:  Sleep Med Clin       Date:  2007-06-01

Review 6.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Authors:  Brian D Kent; Walter T McNicholas; Silke Ryan
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 7.  Sleep-disordered breathing and obesity: pathophysiology, complications, and treatment.

Authors:  Corey J Leinum; John M Dopp; Barbara J Morgan
Journal:  Nutr Clin Pract       Date:  2009-12       Impact factor: 3.080

8.  Obstructive sleep apnea as a risk factor for type 2 diabetes.

Authors:  Nader Botros; John Concato; Vahid Mohsenin; Bernardo Selim; Kervin Doctor; Henry Klar Yaggi
Journal:  Am J Med       Date:  2009-12       Impact factor: 4.965

9.  Prevalence of type 2 diabetes in patients with obstructive sleep apnea in a multi-ethnic sample.

Authors:  Kamran Mahmood; Natasha Akhter; Kamal Eldeirawi; Ergün Onal; John W Christman; David W Carley; James J Herdegen
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

Review 10.  [The unsolved problem of diabetes mellitus type 2 and associated complications].

Authors:  M Morcos; P Humpert; A Bierhaus; P Nawroth
Journal:  Chirurg       Date:  2009-05       Impact factor: 0.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.